Clinical Trials Directory

Trials / Conditions / Gallbladder Adenocarcinoma

Gallbladder Adenocarcinoma

9 registered clinical trials studyying Gallbladder Adenocarcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingTrial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients W
NCT07282912
Yale UniversityPhase 2
RecruitingEvaluating Novel Therapies in ctDNA Positive GI Cancers
NCT05482516
Georgetown UniversityPhase 3
RecruitingSafety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
NCT05430035
West Virginia UniversityEARLY_Phase 1
WithdrawnStudy Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With
NCT04931420
University of ChicagoPhase 2
TerminatedStudy of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM;
NCT03267940
Halozyme TherapeuticsPhase 1
CompletedADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
NCT01825603
University of NebraskaPhase 1
CompletedSorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Me
NCT01093222
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
NCT00361231
Massachusetts General HospitalPhase 2
CompletedCapecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Ca
NCT00142480
Massachusetts General HospitalPhase 2